The New EU Legislation on Pharmacovigilance and Changing Models for Drug Development

ISSN： 0114-5916

Source： Drug Safety, Vol.34, Iss.6, 2011-06, pp. : 529-530

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strengthening and Rationalizing Pharmacovigilance in the EU: Where is Europe Heading to?: A Review of the New EU Legislation on Pharmacovigilance

By Borg John-Joseph

Drug Safety, Vol. 34, Iss. 3, 2011-03 ,pp. : 187-197

Adis International

Access to resources Recommend Favorite

Understanding new EU pharmacovigilance rules

Reactions Weekly, Vol. 1, Iss. 1344, 2011-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

EU health council's drug legislation proposal not in interest of patients

Inpharma, Vol. 1, Iss. 1415, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Clinical Pharmacology: Special Safety Considerations in Drug Development and Pharmacovigilance

By Atuah K.N. Hughes D. Pirmohamed M.

Drug Safety, Vol. 27, Iss. 8, 2004-01 ,pp. : 535-554

Adis International

Access to resources Recommend Favorite

New Postgraduate Qualifications in Pharmacovigilance from the Drug Safety Research Unit in the UK

By Lynn Elizabeth Layton Deborah Shakir Saad

Drug Safety, Vol. 34, Iss. 1, 2011-01 ,pp. : 89-91

Adis International

Access to resources Recommend Favorite